𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Acute motor responses to intravenous levodopa in Parkinsonian patients

✍ Scribed by V. Panzer-Decius; D. Bravi; G. A. Moyle; T. N. Chase

Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
51 KB
Volume
7
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis

Acute motor resDonses to intravenous levodopa in Darkinsonian patients V.

📜 SIMILAR VOLUMES

A trial of dextromethorphan in parkinson
A trial of dextromethorphan in parkinsonian patients with motor response complications
✍ Leo Verhagen Metman; Pierre J. Blanchet; Pepÿn van den Munckhof; Paolo Del Dotto 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 399 KB

## Abstract The effects of the NMDA antagonist dextromethorphan (DM) on levodopa‐associated dyskinesias and motor fluctuations were studied in patients with advanced Parkinson's disease. During initial open‐label dose escalation, 6 of 18 patients reported a beneficial effect at their individually d

Non-NMDA receptor-mediated mechanisms ar
Non-NMDA receptor-mediated mechanisms are involved in levodopa-induced motor response alterations in parkinsonian rats
✍ Concepció Marin; Anna Jimenez; Mercè Bonastre; Thomas N. Chase; Eduardo Tolosa 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 213 KB 👁 1 views

Chronic dopaminomimetic administration to parkinsonian animal models or Parkinson's disease patients leads to characteristic alteration in motor response. Previous studies suggested that the nonphysiologic stimulation of dopaminergic receptors on striatal medium spiny neurons enhances the synaptic e

Longitudinal study of the motor response
Longitudinal study of the motor response to levodopa in Parkinson's disease
✍ Benjamin G. Clissold; Craig D. McColl; Katrina R. Reardon; Mark Shiff; Peter A. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 1 views

## Abstract In this prospective study of 34 patients with Parkinson's disease, measurements of the short duration levodopa motor response have been performed in defined __off__ states at 3 yearly intervals over a mean period of 11.4 years from the point of commencement of levodopa treatment. Twenty

Acute doxorubicin toxicity relationship
Acute doxorubicin toxicity relationship to pretreatment liver function, response, and pharmacokinetics in patients with acute nonlymphocytic leukemia
✍ Dean E. Brenner; Peter H. Wiernik; Margaret Wesley; Nicholas R. Bachur 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 641 KB

To determine if there is a relationship between development of acute doxorubicin toxicity, pretreatment liver function studies, and response, 64 acute nonlymphocytic leukemia patients undergoing induction chemotherapy with doxorubicin and cytosine arabinoside were evaluated. No statistically signifi

Antibody responses to hepatitis C envelo
Antibody responses to hepatitis C envelope proteins in patients with acute or chronic hepatitis C
✍ Fournillier-Jacob, Anne; Lunel, Françoise; Cahour, Annie; Cresta, Pascale; Frang 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 976 KB

Antibody responses to the hepatitis C virus (HCV) envelope proteins E l and E2 were analyzed using two original assays in sera from 86 patients in different stages of disease. A Western blot assay and an immunofluorescence assay (IFA) were developed using envelope proteins produced, respectively, in

Randomized trial of tolcapone versus per
Randomized trial of tolcapone versus pergolide as add-on to levodopa therapy in Parkinson's disease patients with motor fluctuations
✍ William Koller; Andrew Lees; Miroslava Doder; Mariese Hely 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 1 views

## Abstract In this 12‐week, randomized, open‐label, blinded‐rater, parallel‐group trial, the efficacy, safety, and tolerability of tolcapone and pergolide were compared in parkinsonian patients with a fluctuating response to levodopa. Patients received tolcapone 100 mg three times daily (t.i.d.),